US2007027324A1PendingUtilityA1
Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
Est. expiryMar 23, 2021(expired)· nominal 20-yr term from priority
C07D 233/64C07D 263/32
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for producing heterocyclic compounds which are useful as pesticides, drugs, fungicidal materials or intermediates thereof. TosMIC is reacted with an aldehyde or an imino compound: 1) in a solvent mixture of an aprotic solvent with a protic solvent in the presence of a base, 2) in the presence of a phase-transfer catalyst and an inorganic base, or 3) in the presence of an inorganic base. Thus, a desired product can be efficiently obtained using a solution without isolating TosMIC which is irritating and unstable, has a low decomposition point and shows explosivity.
Claims
exact text as granted — not AI-modified1 . A process for the preparation of a 5-substituted oxazole or 5-substituted imidazole comprising
synthesizing p-tolylsulfonylmethylisocyanide from N-(p-tolylsulfonylmethyl)formamide with phosphorus oxychloride, phosgene or diphosgene, and a tertiary amine, to form a p-tolylsulfonylmethylisocyanide solution which is not isolated and purified as crystals, and reacting the p-tolylsulfonylmethylisocyanide solution with an aldehyde or a compound represented by Formula (I): R 1 CH═NR 2 wherein, R 1 and R 2 are each independently an optionally substituted phenyl, an optionally substituted heterocyclic group or an optionally substituted alkyl, wherein the p-tolylsulfonylmethylisocyanide solution is reacted with an aldehyde or a compound of Formula (I) in a mixed solvent of an aprotic solvent and a protic solvent in the presence of potassium hydroxide or sodium hydroxide or mixtures thereof.
2 . (canceled)
3 . A process according to claim 1 in which the protic solvent is one or more solvents selected from the group consisting of water, C 1 to C 10 alcohols and mono- or poly-alkylene glycols.
4 . A process for the preparation of a 5-substituted oxazole or 5-substituted imidazole comprising
synthesizing p-tolylsulfonylmethylisocyanide from N-(p-tolylsulfonylmethyl) formamide with phosphorus oxychloride, phosgene or diphosgene, and a tertiary amine, to form a p-tolylsulfonylmethylisocyanide solution which is not isolated and purified as crystals, and reacting the p-tolylsulfonylmethylisocyanide solution with an aldehyde or a compound represented by Formula (I): R 1 CH═NR 2 wherein R 1 and R 2 are each independently an optionally substituted phenyl, an optionally substituted heterocyclic group or an optionally substituted alkyl, wherein the aldehyde or the compound of Formula [I] is reacted with p-tolylsulfonylmethylisocyanide in a mixed solvent of an aprotic solvent and water in the presence of between about 0.0001 moles and about 5 moles of at least one phase-transfer catalyst and an inorganic base.
5 . A process for the preparation of a 5-substituted oxazole or 5-substituted imidazole comprising
synthesizing p-tolylsulfonylmethylisocyanide from N-(p-tolylsulfonylmethyl) formamide with phosphorus oxychloride, phosgene or diphosgene, and a tertiary amine, to form a p-tolylsulfonylmethylisocyanide solution which is not isolated and purified as crystals, and reacting the p-tolylsulfonylmethylisocyanide solution with an aldehyde or a compound represented by Formula (I): R 1 CH═NR 2 wherein R 1 and R 2 are each independently an optionally substituted phenyl, an optionally substituted heterocyclic group or an optionally substituted alkyl, wherein the aldehyde or the compound of Formula [I] is reacted with p-tolylsulfonylmethylisocyanide in the presence of an organic base which has a pKa of 12 or more.
6 . (canceled)
7 . The process according to claim 5 , wherein the organic base is 1,8-diazabicyclo[5.4.0]undec-7-ene or 4-(N,N-dimethylamino)pyridine.
8 . The process according to claim 1 , wherein the aldehyde is an unsubstituted or substituted aromatic aldehyde.
9 - 11 . (canceled)
12 . The process according to claim 4 wherein the aldehyde is an unsubstituted or substituted aromatic aldehyde.
13 . The process according to claim 5 wherein the aldehyde is an unsubstituted or substituted aromatic aldehyde.
14 . The process according to claim 4 , wherein the phase transfer catalyst is at least one phase transfer catalyst selected from the group consisting of quaternary ammonium salts, quaternary phosphonium salts, crown compounds and organic bases.Join the waitlist — get patent alerts
Track US2007027324A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.